EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
Recruiting · NCT07478016 · Observational (researchers observe without assigning treatment) · Lead sponsor: Thomas Jefferson University
View the official record on ClinicalTrials.gov →Interventions studied
Blood Biomarker CollectionDiet RecallSurvey Assessments
What this trial is about
This is a pilot trial to assess how measures of inflammation are correlated with Social Determinants of Health (SDoH) in breast cancer patients. Expected duration of subject participation is one single time point. The patients will fill out questionnaires and provide a plasma sample.
Who can take part
Age range
18 Years and older
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Individuals must meet all the following inclusion criteria to be eligible to participate in the study:
- Female
- \>18 years old at time of consent
- Biopsy proven invasive breast cancer or ductal carcinoma in situ
- Candidate has not yet received cancer therapy for their breast cancer diagnosis
- ECOG Performance Status \< 2
- Able to provide consent
- Must be English speaking
Exclusion criteria
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Patient has started therapy or already had definitive oncologic surgery
- Another malignancy within the past 6 months that was not a non-melanomatous skin lesion
Where it is running
1 location listed across 1 US state.
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University - Philadelphia, Pennsylvania, United States